Moyamoya Disease Clinical Trial
Official title:
Development and Validation for Muti-stage Prognostic Prediction Model in Patients With Moyamoya Disease Undergoing Revascularization Surgery
Moyamoya Disease (MMD) is a rare chronic cerebrovascular disease characterized by progressive occlusion of the internal carotid artery or its major branches, with blood flow compensated by the formation of an abnormal vascular network (smoky). According to the latest national epidemiological survey in 2022, the cumulative number of new cases in the population was 47,443 in two years, with the annual incidence rate increasing year by year. The first symptoms are mainly cerebral infarction, transient ischemic attack, intracranial hemorrhage, and epileptic seizure, and the onset of the disease is concentrated in the age group of 45-54 years old, which is one of the most important causes of new strokes in middle-aged and young people and imposes a heavy medical burden on the society and the family. As one of the major causes of new strokes in young and middle-aged people, it brings a heavy medical burden to society and families. Hemodialysis has been confirmed as a standard treatment for patients with smokers' disease in large sample studies to prevent bleeding and recurrence of hemorrhage; however, there is no better consensus on which anesthetic technique to use for hemodialysis in patients with MMD. Currently, the more perfect prediction model is the postoperative collateral compensation formation prediction model for direct and indirect hemodialysis, which has the advantage of making full use of the patients' preoperative baseline variables and imaging characteristics, but the relatively insufficient inclusion of the sample size and the lack of intraoperative (vital signs, respiratory parameters, local cerebral oxygenation, etc.) and postoperative (postoperative neurological injury markers, etc.) variables included in the model limits the clinical scenarios. The lack of intraoperative (vital signs, respiratory parameters, local cerebral oxygen saturation) and postoperative (postoperative neurologic injury markers) variables limits the clinical application scenarios and is unable to guide the clinical decision-making and prognosis in the important stages of the perioperative period. This study aims to establish a prospective cohort database for MMD hemodialysis that includes perioperative anesthesia management, intraoperative treatment data, and postoperative treatment variables; to integrate preoperative, intraoperative, postoperative, and near- and long-term prognostic data from multiple sources, and to construct a perioperative multi-stage, multi-dimensional prognostic prediction model.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03785171 -
Predicative Value of Multimodal MRI in Moyamoya Disease
|
||
Recruiting |
NCT05619068 -
The Evolution and Prognosis of Moyamoya Disease
|
||
Recruiting |
NCT03613701 -
Relationship Between Endothelial Progenitor Cells and Revascularization Effect of Moyamoya Disease
|
||
Recruiting |
NCT06041659 -
Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia
|
||
Suspended |
NCT04064658 -
Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease Patients
|
N/A | |
Recruiting |
NCT03627975 -
Effect of Surgical Revascularization on Hemorrhagic Moyamoya Disease
|
N/A | |
Not yet recruiting |
NCT06330818 -
Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients
|
N/A | |
Recruiting |
NCT05332756 -
Long-term Outcomes of Conservative Management in Patients With Moyamoya Disease and Their First-degree Relatives (LAMORA)
|
||
Recruiting |
NCT04890782 -
Gut Microbiota in Patients With Moyamoya Disease
|
||
Completed |
NCT03162588 -
Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya
|
Phase 1/Phase 2 | |
Completed |
NCT03072914 -
Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome
|
N/A | |
Recruiting |
NCT02305407 -
Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery
|
N/A | |
Recruiting |
NCT04917003 -
Safety and Efficacy of Remote Ischemic Conditioning Combined EDAS on Ischemic Moyamoya Disease
|
N/A | |
Completed |
NCT04012268 -
The Safety and Efficacy of RIC on Adult Moyamoya Disease
|
N/A | |
Not yet recruiting |
NCT04205578 -
NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events
|
Phase 3 | |
Recruiting |
NCT02982135 -
Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease
|
N/A | |
Recruiting |
NCT02074111 -
Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke
|
N/A | |
Recruiting |
NCT04696094 -
The Role of m6A RNA Modification in Moyamoya Disease
|
||
Completed |
NCT04906564 -
RNF213 Variants and Collateral Vessels in Moyamoya Disease
|
||
Recruiting |
NCT05961748 -
Registry of Multicenter Brain-Heart Comorbidity in China
|